Multicomponent (bio)markers for obesity risk prediction: a scoping review protocol.

"Competing interests: MSD works as a consultant and an advisory board member at Theralution, Germany. Otherwise, the authors declare no conflict of interest."

"Funding: This research is being conducted as part of the HealthyW8 project, which received funding from the European Union's Horizon Europe Research and Innovation Programme under the grant agreement no 101080645. JAT, CB, AS and MM-M are also funded by CIBEROBN (CB12/03/30038) of the Instituto de Salud Carlos III, Spain. YD has received funding from the EU Horizon 2020 project COVIRNA (grant agreement # 101016072), the National Research Fund (grants # C14/BM/8225223, C17/BM/11613033 and COVID-19/2020-1/14719577/miRCOVID), the COST Association (Actions # CA17129 and CA21153), the Ministry of Higher Education and Research (no specific grant no.) and the Heart Foundation-Daniel Wagner of Luxembourg (no specific grant no)."